We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $12.4B
1-Year Est. Return 64.17%
This Fund
S&P 500
This Quarter Est. Return
+2.33%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$33.9B
AUM Growth
-$1.05B
Cap. Flow
-$1.27B
Cap. Flow %
-3.76%
Top 10 Hldgs %
9.76%
Holding
1,528
New
93
Increased
461
Reduced
505
Closed
116
Avg Time Held
2.7 quarters
Top 10 Avg Time Held
1.9 quarters
Top 20 Avg Time Held
2 quarters

Top Buys

Rank Stock Value
1
MDCO
Medicines Co
MDCO
+$50.1M
2
GCO icon
Genesco
GCO
+$46.4M
3
DAN icon
Dana Inc
DAN
+$41.3M
4
KW icon
Kennedy-Wilson Holdings
KW
+$31.1M
5
JBTM icon
JBT Marel
JBTM
+$30.8M

Sector Composition

Rank Sector Weight
1 Industrials 24.41%
2 Technology 17.65%
3 Consumer Discretionary 14.64%
4 Financials 10.23%
5 Materials 9.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CGNX icon
26
Cognex
CGNX
$10.6B
$178M 0.53%
10,502,408
-284,800
-3% -$5.32M
2013 Q2
3 quarters
KW icon
27
DELISTED
Kennedy-Wilson Holdings
KW
$177M 0.52%
7,868,360
+1,311,970
+20% +$31.1M
2013 Q2
3 quarters
CPRT icon
28
Copart
CPRT
$24.8B
$174M 0.52%
38,344,736
+38,400
+0.1% +$170K
2013 Q2
3 quarters
JLL icon
29
Jones Lang LaSalle
JLL
$13.8B
$174M 0.51%
1,470,383
+33,100
+2% +$3.81M
2013 Q2
3 quarters
MDCO
30
DELISTED
Medicines Co
MDCO
$174M 0.51%
6,115,200
+1,515,358
+33% +$50.1M
2013 Q2
3 quarters
KMT icon
31
Kennametal
KMT
$2.44B
$173M 0.51%
3,909,860
-368,178
-9% -$16.9M
2013 Q2
3 quarters
GSM icon
32
FerroAtlántica
GSM
$775M
$172M 0.51%
8,279,238
-740,043
-8% -$14M
2013 Q2
3 quarters
NATI
33
DELISTED
National Instruments Corp
NATI
$172M 0.51%
5,994,551
– –
2013 Q2
3 quarters
BBBY
34
DELISTED
Bed Bath & Beyond Inc
BBBY
$167M 0.49%
2,425,477
+124,177
+5% +$8.41M
2013 Q2
3 quarters
GCO icon
35
Genesco
GCO
$394M
$166M 0.49%
2,224,225
+638,296
+40% +$46.4M
2013 Q3
2 quarters
PAAS icon
36
Pan American Silver
PAAS
$19B
$165M 0.49%
12,821,103
+412,500
+3% +$5.52M
2013 Q2
3 quarters
FINL
37
DELISTED
Finish Line
FINL
$160M 0.47%
5,915,400
-65,524
-1% -$1.74M
2013 Q2
3 quarters
RVTY icon
38
Revvity
RVTY
$17.2B
$160M 0.47%
3,540,320
-37,300
-1% -$1.64M
2013 Q2
3 quarters
NUS icon
39
Nu Skin
NUS
$238M
$159M 0.47%
1,923,923
-263,285
-12% -$23.1M
2013 Q2
3 quarters
FCS
40
DELISTED
FAIRCHILD SEMICONDUCTOR INTL INC COMMON
FCS
$159M 0.47%
11,497,071
-476,300
-4% -$6.36M
2013 Q2
3 quarters
EME icon
41
Emcor
EME
$34.5B
$151M 0.45%
3,231,639
-15,900
-0.5% -$700K
2013 Q2
3 quarters
IOSP icon
42
Innospec
IOSP
$2.36B
$149M 0.44%
3,300,604
+224,504
+7% +$9.89M
2013 Q2
3 quarters
CRUS icon
43
Cirrus Logic
CRUS
$5.39B
$147M 0.44%
7,411,750
+711,169
+11% +$13.5M
2013 Q2
3 quarters
SSD icon
44
Simpson Manufacturing
SSD
$7.01B
$147M 0.43%
4,150,433
– –
2013 Q2
3 quarters
IDXX icon
45
Idexx Laboratories
IDXX
$41.2B
$146M 0.43%
2,407,822
-582,800
-19% -$34.7M
2013 Q2
3 quarters
LSTR icon
46
Landstar System
LSTR
$5.72B
$146M 0.43%
2,457,440
– –
2013 Q2
3 quarters
MSM icon
47
MSC Industrial Direct
MSM
$7.25B
$145M 0.43%
1,680,639
+26,500
+2% +$2.26M
2013 Q2
3 quarters
SAFM
48
DELISTED
Sanderson Farms Inc
SAFM
$145M 0.43%
1,850,514
-25,800
-1% -$1.92M
2013 Q2
3 quarters
AXE
49
DELISTED
Anixter International Inc
AXE
$144M 0.43%
1,419,659
-12,800
-0.9% -$1.25M
2013 Q2
3 quarters
CKH
50
DELISTED
Seacor Holdings Inc.
CKH
$142M 0.42%
1,702,924
-42,911
-2% -$3.58M
2013 Q2
3 quarters

Similar funds

Royce & Associates's Q1 2014 Portfolio in Review

As of Q1 2014, Royce & Associates held 1,528 positions worth $33.9B, down 3% from $34.9B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Royce & Associates withdrew a net $1.27B in Q1 2014, closing 116 positions and reducing 505 holdings. Its most notable exit was ARDEN GROUP INC CL-A, an estimated $34.3M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 24% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Royce & Associates opened a new position in Neenah, Inc. Common Stock worth $23.5M.

  • Royce & Associates's largest Q1 2014 buy was Neenah, Inc. Common Stock: 454,500 shares worth $23.5M.
  • Royce & Associates added most to Medicines Co in Q1 2014, an estimated $50.1M increase.
  • Royce & Associates's biggest Q1 2014 reduction was TOWERS WATSON & CO COM STK CL A (DE), cutting an estimated $87.3M.
  • Royce & Associates fully exited ARDEN GROUP INC CL-A in Q1 2014, selling an estimated $34.3M.
  • Royce & Associates's ten largest holdings make up 9.8% of its $33.9B portfolio in Q1 2014.
  • Royce & Associates opened 93 new positions and closed 116 in Q1 2014.
  • Royce & Associates's portfolio value fell 3% quarter-over-quarter to $33.9B.

Based on Royce & Associates's 13F filing for Q1 2014, filed 12 May 2014.